Harbin Pharmaceutical Group Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 2,979.901 million compared to CNY 2,510.840 million a year ago. Operating income was CNY 133.031 million compared to operating loss of CNY 151.819 million a year ago. Net income was CNY 82.869 million compared to net loss of CNY 186.635 million a year ago. Basic earnings per share from continuing operations was CNY 0.03 compared to basic loss per share from continuing operations of CNY 0.07 a year ago.